Health
UIC conducts three clinical trials to study blood clot prevention in COVID-19 patients – News-Medical.Net
The University of Illinois Chicago will conduct three clinical trials for studying blood clot prevention in patients with COVID-19.
Reviewed by Emily Henderson, B.Sc.Nov 18 2020
The University of Illinois Chicago will conduct three clinical trials for studying blood clot prevention in patients with COVID-19.
Blood clots are one of the leading complications of COVID-19. Patients with COVID-19 often form blood clots throughout their bodies, which, if untreated, can lead to organ damage, including stroke, pulmonary embolism and heart attacks. We need to stop blood clot formation in order to prevent these potentially fatal complications…
-
Noosa News18 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Noosa News20 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
Noosa News23 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call
-
General19 hours agoInternal Revenue Service starts cutting 20,000 workers